Radiotherapy plus anti-PD1 versus radiotherapy for hepatic toxicity in patients with hepatocellular carcinoma

Radiotherapy plus anti-PD1 versus radiotherapy for hepatic toxicity in patients with hepatocellular carcinoma

Abstract Purpose In this study, we aimed to compare the radiation-induced hepatic toxicity (RIHT) outcomes of radiotherapy (RT) plus antibodies against programmed cell death protein 1 (anti-PD1) versus RT alone in patients with hepatocellular carcinoma (HCC), evaluate prognostic factors of non-class...

Full description

Bibliographic Details
Main Authors: Rui-Jun Zhang, Hong-Mei Zhou, Hai-Yan Lu, Hong-Ping Yu, Wei-Zhong Tang, Mo-Qin Qiu, Liu-Ying Yan, Mei-Ying Long, Ting-Shi Su, Bang-De Xiang, Mei-Ling He, Xiao-Ting Wang, Shi-Xiong Liang, Jian-Xu Li
Format: Article
Language:English
Published: BMC 2023-08-01
Series:Radiation Oncology
Subjects:
Anti-PD1
Hepatocellular carcinoma
Propensity score matching
Radiation-induced liver disease
Online Access:https://doi.org/10.1186/s13014-023-02309-1

Internet

https://doi.org/10.1186/s13014-023-02309-1

Similar Items